8-K
filed June 4, 2026, 4:46 PM ET
ticker LFST
CIK 0001845257
other
confidence high
sentiment neutral
materiality 0.10
LifeStance Health annual meeting votes: directors elected, auditor ratified, say-on-pay approved.
LifeStance Health Group, Inc.
- David Bourdon and Robert Bessler elected as Class II directors with 244.97M/83.97M and 280.02M/48.92M for/withhold votes.
- Ratification of PwC as auditor: 357.76M for, 209K against, 751K abstain.
- Non-binding advisory say-on-pay vote passed: 322.90M for, 5.68M against, 354K abstain; 29.78M broker non-votes.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LifeStance Health Group, Inc. shareholders approved Election of Class II Directors at the 2026-06-02 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-02
Exact text from the filing
Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company’s Board of Directors as members of Class II for a term of three years. The results of the vote were as follows: Name of Nominee For Withhold Broker Non-Votes David Bourdon 244,968,319 83,966,052 29,782,714 Robert Bessler 280,015,618 48,918,753 29,782,714
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LifeStance Health Group, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-02
Exact text from the filing
Proposal 2: Ratification of the Company’s Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ended December 31, 2026. The results of the vote were as follows: For Against Abstain 357,756,707 209,431 750,947
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LifeStance Health Group, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2026-06-02 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-02
Exact text from the filing
Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company’s named executive officer compensation. The results of the vote were as follows: For Against Abstain Broker Non-Votes 322,904,359 5,675,861 354,151 29,782,714
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.